DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Jatoi A, Ritter HL, Dueck A. et al.
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
Lung Cancer 2010;
68: 234-239
Access:
We do not assume any responsibility for the contents of the web pages of other providers.